RecruitingNot ApplicableNCT06273800

Chemosensitivity During Phases of the Menstrual Cycle in Breast Cancer Patients


Sponsor

The Netherlands Cancer Institute

Enrollment

100 participants

Start Date

Oct 14, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study is a prospective, multicenter study in which a serum sample will be collected at the day of starting neo adjuvant treatment in breast cancer patients


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 59 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating whether the phase of a woman's menstrual cycle at the time she receives chemotherapy affects how sensitive her tumor cells are to the treatment. The focus is on women with triple-negative breast cancer, which tends to be more aggressive. **You may be eligible if...** - You are a woman under 60 years old - You have a new diagnosis of triple-negative breast cancer (stages I–III) - You have a regular menstrual cycle and have not yet started any systemic treatment - Your doctor has recommended neoadjuvant chemotherapy (chemotherapy before surgery) **You may NOT be eligible if...** - You are currently using hormonal contraception or have recently stopped - You have started any previous systemic cancer treatment - You are menopausal or have an irregular cycle Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREBlood sample

Collection of serum sample at the day of start of neo adjuvant treatment


Locations(1)

Antoni van Leeuwenhoek

Amsterdam, North Holland, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06273800


Related Trials